NasdaqCM - Delayed Quote USD
Adverum Biotechnologies, Inc. (ADVM)
At close: November 5 at 4:00 PM EST
After hours: 7:19 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-85,541.00
-90,902.00
-108,091.00
-107,831.00
-79,291.00
Investing Cash Flow
-47,578.00
96,875.00
141,720.00
78,709.00
-280,167.00
Financing Cash Flow
119,930.00
69.00
607.00
2,397.00
355,985.00
End Cash Position
94,827.00
76,976.00
70,934.00
36,698.00
63,423.00
Capital Expenditure
-519.00
-808.00
-11,816.00
-15,123.00
-11,844.00
Issuance of Capital Stock
--
--
--
1,685.00
344,302.00
Repayment of Debt
--
--
--
-240.00
-61.00
Free Cash Flow
-86,060.00
-91,710.00
-119,907.00
-122,954.00
-91,135.00
12/31/2020 - 7/31/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ORIC ORIC Pharmaceuticals, Inc.
9.68
+2.11%
FDMT 4D Molecular Therapeutics, Inc.
8.39
+2.63%
ALEC Alector, Inc.
4.9950
-5.22%
SLDB Solid Biosciences Inc.
5.94
+4.95%
ALDX Aldeyra Therapeutics, Inc.
5.27
+1.74%
RGNX REGENXBIO Inc.
8.92
+1.83%
OPT Opthea Limited
4.1900
-1.87%
REPL Replimune Group, Inc.
12.02
0.00%
STOK Stoke Therapeutics, Inc.
13.05
-0.38%
ANAB AnaptysBio, Inc.
19.88
-0.30%